Affiliation: University of Vermont
- Interim Buprenorphine vs. Waiting List for Opioid Dependence.Stacey C Sigmon
N Engl J Med 375:2504-2505. 2016
- Bridging waitlist delays with interim buprenorphine treatment: initial feasibilityStacey C Sigmon
Department of Psychiatry, University of Vermont, Burlington, VT, United States Department of Psychology, University of Vermont, Burlington, VT, United States Electronic address
Addict Behav 51:136-42. 2015..A larger-scale, randomized clinical trial is underway to more rigorously examine the efficacy of this treatment approach. ..
- Interim treatment: Bridging delays to opioid treatment accessStacey C Sigmon
Department of Psychiatry, University of Vermont College of Medicine, Vermont Center on Behavior and Health, USA Electronic address
Prev Med 80:32-6. 2015..We review the published research in the 20years since the approval of interim opioid treatment...
- The use of financial incentives in promoting smoking cessationStacey C Sigmon
Department of Psychiatry, University of Vermont, University Health Center Campus, 1 S Prospect St, Burlington, VT 05401, USA
Prev Med 55:S24-32. 2012..We provide a narrative review of published studies evaluating financial incentives for smoking cessation and discuss the parameters important for ensuring the efficacy of incentive interventions for smoking cessation...
- Opioid detoxification and naltrexone induction strategies: recommendations for clinical practiceStacey C Sigmon
Department of Psychiatry, University of Vermont College of Medicine, Burlington, 05401, USA
Am J Drug Alcohol Abuse 38:187-99. 2012..e., methadone, buprenorphine) often produces favorable outcomes, detoxification followed by treatment with the μ-opioid receptor antagonist naltrexone may offer a potentially useful alternative to agonist maintenance for some patients...
- Characterizing the emerging population of prescription opioid abusersStacey C Sigmon
Department of Psychiatry, University of Vermont, Burlington, Vermont 05401, USA
Am J Addict 15:208-12. 2006..This new information may inform and assist current efforts to develop efficacious treatments for prescription opioid abuse...
- Caffeine choice prospectively predicts positive subjective effects of caffeine and d-amphetamineStacey C Sigmon
Department of Psychiatry, University of Vermont College of Medicine, SATC UHC, Room 1415, Burlington, VT 05401, USA
Drug Alcohol Depend 118:341-8. 2011..The present study sought to determine whether individual differences in caffeine choice prospectively predict subjective response to acute doses of caffeine and d-amphetamine...
- Caffeine withdrawal, acute effects, tolerance, and absence of net beneficial effects of chronic administration: cerebral blood flow velocity, quantitative EEG, and subjective effectsStacey C Sigmon
Department of Psychiatry, University of Vermont College of Medicine, SATC UHC, Room 1415, Burlington, VT, 05401, USA
Psychopharmacology (Berl) 204:573-85. 2009..Although the subjective effects of caffeine abstinence, acute and chronic administration, and tolerance are well described, the corresponding neurophysiological effects are not...
- Brief buprenorphine detoxification for the treatment of prescription opioid dependence: a pilot studyStacey C Sigmon
Department of Psychiatry, University of Vermont, United States
Addict Behav 34:304-11. 2009....
- Investigating the pharmacological and nonpharmacological factors that modulate drug reinforcementStacey C Sigmon
Department of Psychiatry, University of Vermont, VT, USA
Exp Clin Psychopharmacol 15:1-20. 2007..In summary, understanding the interactions among the variables present in the context of drug use is critical to understanding risk factors for substance use disorders as well as developing efficacious treatments for drug dependence...
- Voucher-based contingent reinforcement of marijuana abstinence among individuals with serious mental illnessStacey C Sigmon
Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT 05401, USA
J Subst Abuse Treat 30:291-5. 2006....
- An injection depot formulation of buprenorphine: extended bio-delivery and effectsStacey C Sigmon
Behavioral Pharmacology Research Unit, Johns Hopkins University School of Medicine, Baltimore, MD
Addiction 101:420-32. 2006..This report provides a characterization of the bio-delivery of this injectable depot in humans and of the relationship of drug blood levels to pharmacodynamic indices...
- Use of a low-cost incentive intervention to improve counseling attendance among methadone-maintained patientsStacey C Sigmon
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA
J Subst Abuse Treat 29:253-8. 2005..76%) and promoted periods of continuous attendance. These data further support the effectiveness of low-cost incentive programs in enhancing counseling attendance among methadone patients...
- Open-label trial of an injection depot formulation of buprenorphine in opioid detoxificationBai Fang X Sobel
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224 6823, USA
Drug Alcohol Depend 73:11-22. 2004..Results from the present study suggest that depot buprenorphine offers significant promise for enhancing the delivery of effective opioid agonist treatment while minimizing risk for abuse of the medication...
- Evaluation of ongoing oxycodone abuse among methadone-maintained patientsKelly E Dunn
Department of Psychology, University of Vermont, Burlington, VT, USA
J Subst Abuse Treat 35:451-6. 2008....
- Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: a pilot studyKelly E Dunn
University of Vermont, USA
J Appl Behav Anal 41:527-38. 2008..These results support the potential efficacy of using voucher-based CM to promote smoking cessation among methadone-maintained patients...
- Evaluation of an injection depot formulation of buprenorphine: placebo comparisonStacey C Sigmon
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Addiction 99:1439-49. 2004..The present study examined the efficacy of depot buprenorphine in suppressing the opioid withdrawal syndrome and in attenuating the effects of exogenous opioid challenge...
- Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusersBai Fang X Sobel
Department of Psychiatry and Behavioral Science, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
Neuropsychopharmacology 29:991-1003. 2004..The results of the present study demonstrate that chronic nicotine maintenance produces tolerance to the effects of intravenous nicotine, but does not affect the subjective or reinforcing effects of cocaine or caffeine...
- Characterizing and improving HIV/AIDS knowledge among cocaine-dependent outpatientsSarah H Heil
Substance Abuse Treatment Center, Department of Psychiatry, University of Vermont, 1 South Prospect Street, Burlington, VT 05401 1419, USA
Exp Clin Psychopharmacol 13:238-43. 2005..Results support the intervention's efficacy for increasing HIV/AIDS knowledge among cocaine-dependent outpatients. This intervention is brief, inexpensive, and easily implemented...
- Examining possible gender differences among cocaine-dependent outpatientsConrad J Wong
Department of Psychology, University of Vermont, Burlington 05401, USA
Exp Clin Psychopharmacol 10:316-23. 2002..Women reported a lower frequency of alcohol use before intake, and fewer women than men met criteria for cannabis dependence. Men and women experienced comparable improvement during the course of treatment and follow-up...
- Community reinforcement therapy for cocaine-dependent outpatientsStephen T Higgins
Departments of Psychiatry, Medical Biostatistics, and Psychology, University of Vermont, Burlington, VT 05401, USA
Arch Gen Psychiatry 60:1043-52. 2003..To examine the contributions of community reinforcement therapy to outcome in the community reinforcement approach (CRA) + vouchers outpatient treatment for cocaine dependence...
- Comparison of characteristics of opioid-using pregnant women in rural and urban settingsSarah H Heil
Department of Psychiatry, University of Vermont, Burlington, Vermont, USA
Am J Drug Alcohol Abuse 34:463-71. 2008..g., less severe drug use, greater employment). However, they may face additional barriers in accessing treatment (e.g., greater distance from treatment clinic)...
- Cocaine abstinence during methadone maintenance: effects of repeated brief exposure to voucher-based reinforcementStacey C Sigmon
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Exp Clin Psychopharmacol 12:269-75. 2004..The study supports brief abstinence test efficacy but did not find that unpredictable opportunities to earn incentives generalized to nonreinforced days...
- Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxoneRichard N Rosenthal
Department of Psychiatry, St Luke s Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY, USA
Addiction 108:2141-9. 2013..To evaluate the safety and efficacy of buprenorphine implants (BI) versus placebo implants (PI) for the treatment of opioid dependence. A secondary aim compared BI to open-label sublingual buprenorphine/naloxone tablets (BNX)...
- Cash value of voucher reinforcers in pregnant drug-dependent womenJames Rosado
Department of Psychiatry, Harvard Medical School, Cambridge, MA, USA
Exp Clin Psychopharmacol 13:41-7. 2005..These results suggest that voucher discounting does occur among patients in drug treatment. However, vouchers retain 80%-90% of their cash value and thus remain relatively potent reinforcers...
- Examining interrelationships between abstinence and coping self-efficacy in cocaine-dependent outpatientsConrad J Wong
University of Vermont, Department of Psychology, Burlington, VT, USA
Exp Clin Psychopharmacol 12:190-9. 2004..Results suggest a unidirectional relationship wherein prior abstinence predicts subsequent abstinence and confidence...
- Acute effects of D-amphetamine on progressive-ratio performance maintained by cigarette smoking and moneyStacey C Sigmon
Department of Psychology, University of Vermont, 38 Fletcher Place, Burlington, VT 05401, USA
Psychopharmacology (Berl) 167:393-402. 2003..Psychomotor stimulants often increase cigarette smoking, although the mechanisms responsible for that effect remain unclear...
- A contingency-management intervention to promote initial smoking cessation among opioid-maintained patientsKelly E Dunn
Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Exp Clin Psychopharmacol 18:37-50. 2010..Results from this randomized clinical trial support the efficacy of contingency management interventions in promoting initial smoking abstinence in this challenging population...
- A comparison of voucher-delivery schedules for the initiation of cocaine abstinenceChristopher J Correia
Department of Psychology, Auburn University, 226 Thach Hall, Auburn, AL 36849, USA
Exp Clin Psychopharmacol 13:253-8. 2005..However, contrary to the initial hypothesis, the shaping reinforcement condition did not increase rates of abstinence on the final abstinence test...
- Morphine tolerance as a function of ratio schedule: response requirement or unit price?Christine E Hughes
Department of Psychology, University of North Carolina Wilmington, 601 S College Road, Wilmington, North Carolina 28403 5612, USA
J Exp Anal Behav 83:281-96. 2005..The morphine data suggest that the fixed-ratio value (i.e., the absolute output) determines the degree of tolerance and not the unit price...
- Effective Treatment for Prescription Opioid AbuseSTACEY SIGMON; Fiscal Year: 2009..Development of efficacious treatments for this emerging population will help to reduce the vast economic and societal costs associated with prescription opioid abuse. ..